Screener / SEC EDGAR /CIK 0001576280 /10-K filed Feb 19, 2026, compared with Feb 20, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Medical Labs

Guardant Health, Inc. GH

Compare with peers Embed
Planned sales, announced before they happen

6 trading plans running, 58 Form 144 notices for $193.6M

10-Q, 10-K and Form 144
Plans running now 6 Terilyn Monroe, Alex M. Azar II, Meghan Joyce, Musa Tariq, John Saia, AmirAli Talasaz
Plans adopted 12 reported since May 9, 2023 Form 144 notices 58 $193.6M the sellers expected to sell

What GH's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Sep 11, 2024 to Oct 6, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Terilyn Monroe
Chief People Officer
Adopted 10b5-1 plan Aug 19, 2026 10-Q Nov 5, 2026
What the company wrote
During the fiscal quarter ended September 30, 2026, none of our directors or officers adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Item 408 of Regulation S-K, except as described in the table below: Name and Title of Insider Adoption, Modification or Termination Applicable Date Duration of Trading Arrangement Rule 10b5-1 Trading Arrangement? (Y / N) (1) Aggregate Number of Securities Subject to the Trading Arrangement Terilyn Monroe, Chief People Officer Adoption 8/19/2026 11/18/2026 - 10/6/2027 Y Indeterminable (2) ______________ (1) Denotes whether the trading plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) when adopted. (2) The 10b5-1 trading plan provides for the sale of 50% to 100% of an indeterminable number of shares of our common stock underlying certain restricted stock unit awards and performance stock unit awards that will vest during the duration of the trading arrangement.
Alex M. Azar II
Director
Adopted 10b5-1 plan May 21, 2026 10-Q Jul 30, 2026
What the company wrote
During the fiscal quarter ended June 30, 2026, none of our directors or officers adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as those terms are defined in Item 408 of Regulation S-K, except as described in the table below: Name and Title of Insider Adoption, Modification or Termination Applicable Date Duration of Trading Arrangement Rule 10b5-1 Trading Arrangement? (Y / N) (1) Aggregate Number of Securities Subject to the Trading Arrangement Alex M. Azar II, Director Adoption 5/21/2026 8/19/2026 - 9/15/2027 Y Indeterminable (2) ______________ (1) Denotes whether the trading plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) when adopted. (2) The 10b5-1 trading plan provides for the sale of 50% of an indeterminable number of shares of our common stock underlying certain restricted stock unit awards that will vest during the duration of the trading arrangement.
Meghan Joyce
Director
Adopted 10b5-1 plan Mar 4, 2026 10-Q May 7, 2026
Musa Tariq
Director
Adopted 10b5-1 plan Dec 17, 2025 10-K Feb 19, 2026
John Saia
Chief Legal Officer and Secretary
Adopted 10b5-1 plan Dec 16, 2025 10-K Feb 19, 2026
AmirAli Talasaz
Co-Chief Executive Officer and Director
Adopted 10b5-1 plan Dec 5, 2025 10-K Feb 19, 2026
Amir Ali Talasaz
Ended 10b5-1 plan Aug 26, 2025 10-Q Oct 29, 2025
Terilyn Juarez Monroe
Chief People Officer
Adopted 10b5-1 plan Aug 2, 2025 10-Q Oct 29, 2025
Myrtle Potter
Director
Adopted 10b5-1 plan Mar 15, 2025 10-Q Apr 30, 2025
AmirAli Talasaz
Co-Chief Executive Officer and Director
Adopted 10b5-1 plan Dec 17, 2024 10-K Feb 20, 2025
Musa Tariq
Director
Adopted 10b5-1 plan Sep 11, 2024 10-Q Nov 6, 2024
Meghan Joyce
Director
Adopted 10b5-1 plan Aug 13, 2024 10-Q Nov 6, 2024
AmirAli Talasaz
Co-Chief Executive Officer and Director
Adopted plan – 10-Q Oct 29, 2025
Show the other 5 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 9, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Oct 16, 2026 Tariq Musa
Director
116 $19K
Oct 14, 2026 Azar Alex M II
Director
69 $11K
Sep 16, 2026 Tariq Musa
Director
116 $20K
Sep 16, 2026 Azar Alex M II
Director
826 $145K
Sep 16, 2026 Krognes Steve E.
Director
6,674 $1.2M
Sep 15, 2026 Chudova Darya
Officer
7,738 $1.4M
Sep 11, 2026 Kalia Kumud
Officer
4,000 $632K
Aug 21, 2026 Talasaz AmirAli
Officer
37,500 $6.3M
Aug 17, 2026 Tariq Musa
Director
116 $18K
Aug 12, 2026 Monroe Terilyn J.
Officer
46,300 $7.6M
Aug 10, 2026 Freeman Chris
Officer
63,605 $10.8M
Aug 5, 2026 Hidalgo Medina Manuel
Director
1,700 $279K
Aug 5, 2026 Joyce Meghan V.
Former Affiliate
11,183 $1.8M
Aug 4, 2026 CLARK IAN T
Director
14,180 $2.3M
Jul 16, 2026 Tariq Musa
Director
116 $19K
Jul 1, 2026 Joyce Meghan V.
Director
4,000 $660K
Jun 26, 2026 Talasaz AmirAli
Officer
260,000 $39.2M
Jun 26, 2026 Joyce Meghan V.
Director
2,000 $300K
Jun 24, 2026 Joyce Meghan V.
Director
2,000 $280K
Jun 22, 2026 POTTER MYRTLE S
Director
1,556 $204K
Jun 22, 2026 Tariq Musa
Director
1,951 $256K
Jun 22, 2026 Joyce Meghan V.
Director
6,203 $813K
Jun 16, 2026 Tariq Musa
Director
116 $15K
Jun 15, 2026 Kalia Kumud
Policy-Making Officer
600 $79K
Jun 15, 2026 Kalia Kumud
Policy-Making Officer
600 $79K
Jun 15, 2026 Kalia Kumud
Officer
3,418 $445K
Jun 10, 2026 Kalia Kumud
Officer
5,000 $652K
Jun 5, 2026 Eltoukhy Helmy
Officer
100,000 $12.6M
Jun 5, 2026 Bell Michael Brian
Officer
2,000 $257K
Jun 4, 2026 Krognes Steve E.
Director
9,294 $1.2M
Jun 3, 2026 Joyce Meghan V.
Director
10,000 $1.3M
May 28, 2026 Hidalgo Medina Manuel
Director
1,000 $130K
May 22, 2026 EAGLE CRAIG
Former Affiliate
160,817 $19.1M
May 22, 2026 Freeman Chris
Officer
24,406 $2.9M
May 20, 2026 Saia John G.
Officer
30,000 $3.2M
May 20, 2026 CLARK IAN T
Director
6,876 $735K
May 20, 2026 Hidalgo Medina Manuel
Director
1,250 $134K
May 18, 2026 Tariq Musa
Director
116 $11K
May 12, 2026 Talasaz AmirAli
Officer
260,000 $26.1M
Apr 16, 2026 Tariq Musa
Director
116 $10K
Apr 6, 2026 Monroe Terilyn J.
Officer
3,832 $355K
Mar 18, 2026 Tariq Musa
Director
348 $31K
Mar 16, 2026 Bell Michael Brian
Officer
3,000 $261K
Mar 6, 2026 Hidalgo Medina Manuel
Director
1,300 $119K
Mar 4, 2026 Kalia Kumud
Officer
40,000 $3.8M
Jan 21, 2026 Monroe Terilyn J.
Officer
8,571 $978K
Jan 7, 2026 Monroe Terilyn J.
Officer
10,031 $1.1M
Dec 17, 2025 Tariq Musa
Director
116 $12K
Dec 15, 2025 Eltoukhy Helmy
Officer
90,565 $9.4M
Dec 8, 2025 Talasaz AmirAli
Officer
100,000 $10.5M
Dec 8, 2025 Chudova Darya
Officer
28,780 $3.0M
Dec 8, 2025 Hidalgo Medina Manuel
Director
1,250 $131K
Dec 8, 2025 Kalia Kumud
Officer
2,000 $209K
Dec 5, 2025 Freeman Chris
Officer
31,452 $3.2M
Dec 5, 2025 CLARK IAN T
Director
28,611 $3.1M
Dec 5, 2025 Bell Michael Brian
Officer
80,362 $8.3M
Dec 1, 2025 Monroe Terilyn J.
Officer
55,167 $5.8M
Nov 19, 2025 Tariq Musa
Director
116 $11K
Show the other 50 notices

From the Form 144 XML filed with the SEC, since Nov 19, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/GH/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.